Cadrenal Therapeutics Inc. (CVKD) Social Stream
CADRENAL THERAPEUTICS INC (CVKD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CADRENAL THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-11-20 | 2 | $3 | $3 | $3 | $0.592 | 406.76% |
| 2023-12-18 | 2 | $4 | $3 | $3.5 | $0.592 | 491.22% |
| NA | 1 | $NA | $NA | $NA | $0.592 | NA% |
CVKD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how CADRENAL THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 5.66% of that group.
- CVKD has a greater average analyst price target than 5.36% of all US stocks.
- CVKD has a lower variance in analysts' estimates than 85.6% of Pharmaceutical Products stocks.
- CADRENAL THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 238.21% of Healthcare stocks.
In the Pharmaceutical Products industry, GDTC, UNCY, and RNAZ are the three stocks most similar to CADRENAL THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for CVKD? Use POWR Ratings for clearer insight into price direction.